A-081

Aripiprazole-d₈ solution

100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant^®

• Formule empirique (notation de Hill): C₂₃D₈H₁₉Cl₂N₃O₂
• Numéro CAS: 1089115-04-7
• Poids moléculaire : 456.43
• Numéro CE : 200-835-2
• Numéro MDL: MFCD08460937
• Code UNSPSC : 41116107
• ID de substance PubChem : 329770633
• Nomenclature NACRES : NA.24

Propriétés

• Qualité: certified reference material
• Niveau de qualité: 300
• Forme: liquid
• Caractéristiques: SNAP-N-SPIKE^®, SNAP-N-SHOOT^®
• Conditionnement: ampule of 1 mL
• Fabricant/nom de marque: Cerilliant^®
• Concentration: 100 μg/mL in acetonitrile
• Technique(s): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Application(s): clinical testing
• Format: single component solution
• Température de stockage: −20°C
• Chaîne SMILES: O=C(N1)CCC(C1=C2)=CC=C2OC([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])N(CC3)CCN3C4=CC=CC(Cl)=C4Cl
• InChI: 1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)/i1D2,2D2,10D2,15D2
• Clé InChI: CEUORZQYGODEFX-BQLKVSHCSA-N

Description

Description générale

Aripiprazole, marketed as Abilify^®, is an atypical antipsychotic and antidepressant drug used to treat schizophrenia, bipolar disorder, and clinical depression. This new internal standard is suitable for the quantitation of aripiprazole in biological samples using LCMS or GCMS applications.

Application

• Analyzing Analgesic Effects: The impact of Bromelain versus placebo on postoperative pain in cats was evaluated, where Meperidine solution was likely used as a control analgesic, aiding in the assessment of alternative pain relief methods in veterinary medicine (Ribeiro et al., 2023).


• Data on Pharmacogenomics: A study provided data on the first report of pharmacogenomics profiling in an outpatient spine setting, likely involving Meperidine solution for understanding individual variability in drug metabolism, which is crucial for personalized medicine approaches in pain management (Cottrill et al., 2021).

Informations légales

Abilify is a registered trademark of Otsuka Pharmaceutical Co.

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Informations sur la sécurité

• Pictogrammes: GHS02,GHS07
• Mention d'avertissement: Danger
• Mentions de danger: H225,H302 + H312 + H332,H319
• Conseils de prudence: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338
• Classification des risques: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
• Code de la classe de stockage: 3 - Flammable liquids
• Classe de danger pour l'eau (WGK): WGK 2
• Point d'éclair (°F): 35.6 °F - closed cup
• Point d'éclair (°C): 2 °C - closed cup